A Polish biotech company offers a scalable technology of decellularized extracellular matrix (dECM) production from various tissues.
A Polish “spin-off” company from Adam Mickiewicz University in Poznan, specialized in biometarials, tissue engineering and 3D bioprinting aims to commercialize the technology of dECM production from various tissues. The technology is scalable, detergent-free, and has been validated on porcine menisci. The company seeks to establish international parterships aiming at commercialization of the dECM-based products.